Cardiovascular Digital Solutions Market Report 2025

The cardiovascular digital solutions market size has grown strongly in recent years. It will grow from $98.23 billion in 2024 to $108.04 billion in 2025 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to rise in cardiovascular diseases, telemedicine adoption, data analytics for risk prediction, patient engagement initiatives, remote patient monitoring.

The cardiovascular digital solutions market size is expected to see rapid growth in the next few years. It will grow to $161.57 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to artificial intelligence and machine learning integration, expanding role of digital biomarkers, remote cardiac rehabilitation programs, interoperability of healthcare systems, focus on real-time monitoring and alerts. Major trends in the forecast period include blockchain for secure health data management, integration of EHRS and cardiovascular digital solutions, mobile health apps for cardiovascular management, focus on cardiovascular rehabilitation solutions, collaborations between tech companies and healthcare providers.

The increasing prevalence of cardiovascular diseases (CVDs) worldwide is anticipated to drive the growth of the cardiovascular digital solutions market in the future. CVDs encompass a range of conditions affecting the heart and blood vessels, representing a widespread health concern. Cardiovascular digital solutions empower patients by enabling them to self-monitor health activities that can reduce risk factors and encourage adherence to lifestyle changes. The implementation of these solutions has been shown to lower morbidity and mortality rates associated with cardiovascular diseases. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK government department, revealed that in 2023, there were over 1,862,500 individuals (3%) diagnosed with coronary heart disease in England. As such, the rise in cardiovascular disease prevalence globally is fueling the growth of the cardiovascular digital solutions market.

The anticipated rise in telehealth visits is expected to drive the growth of the cardiovascular digital solutions market in the future. Telehealth involves utilizing digital communication technologies to deliver remote healthcare services and support. Cardiovascular digital solutions enhance the effectiveness of telehealth visits by facilitating real-time monitoring and analysis of cardiac health metrics, which promotes comprehensive remote patient care. For instance, data from Telehealth.HHS.gov, a US government information provider, indicated that in the fourth quarter of 2023, telehealth usage reached approximately 21,883,731 users, marking an increase of 2,783,159 users, or a 13% rise compared to the previous quarter. Therefore, the growth in telehealth visits is significantly contributing to the expansion of the cardiovascular digital solutions market.

Product innovation stands out as a key trend within the cardiovascular digital solutions market, with major companies actively focusing on developing innovative products to strengthen their market positions. In February 2023, Eko Health, a US-based manufacturer of digital health solutions for heart and lung diseases, introduced the SENSORA Cardiac Disease Detection Platform. SENSORA is a cutting-edge cardiovascular disease detection platform that integrates advanced machine learning with the widely used medical device, the stethoscope. By harnessing AI to reliably recognize structural murmurs indicating heart valve disease, SENSORA offers a comprehensive solution for cardiac disorder detection. This innovation showcases the industry's commitment to leveraging digital technologies for enhanced diagnosis and patient care in the cardiovascular digital solutions market.

Prominent companies in the cardiovascular digital solutions market are strategically focusing on the development of innovative therapeutic solutions, with a particular emphasis on digital therapeutics solutions, to advance cardiac care. Digital therapeutics solutions refer to technology-based interventions or software designed to prevent, manage, or treat specific medical conditions. In January 2023, Lupin Digital Health, an India-based software company, launched LYFE, a digital therapeutics solution specifically tailored for cardiac care and developed in collaboration with Indian cardiologists. LYFE utilizes FDA and CE-approved wearables for real-time vital monitoring, emergency notifications, and medication reminders. The platform incorporates expert intervention through care managers, health coaches, and nutritionists, with the overarching goal of enhancing patient outcomes, improving therapy adherence, and reducing caregiver stress.

In May 2024, DHC Group Co. LLC, a UAE-based company specializing in integrated engineering, procurement, and construction solutions for the energy sector, acquired ECG On-Demand for an undisclosed sum. This acquisition is intended to strengthen DHC Group Co. LLC's position as a leading provider of specialized outpatient pathways and diagnostic services by incorporating ECG On-Demand into its operations. The collaboration aims to enhance access to high-quality 12-lead ECG interpretation and Holter monitoring services within both the NHS and private sectors. ECG On-Demand is a UK-based provider of innovative healthcare services, concentrating on cardiovascular digital solutions to improve patient care and management.

Major companies operating in the cardiovascular digital solutions market include iRythm Technologies Inc., Apple Inc., General Electric Company, Uber Diagnostics Private Limited, AlivCor Inc., Verily Life Sciences, HeartFlow Inc., Bardy Diagnostics Inc., BioTelemetry Inc., eviCore healthcare, Nanowear Inc, Cardiac Insight Inc., Bay Labs Solutions, Change Healthcare, Medtronic PLC, BenevolentAI Limited, Cardiologs Technologies, Cardiopulmonary Corp., Congenica Ltd., Cyient Limited, Data4Cure Inc., Deep Genomics Incorporated, DNAnexus Inc., Emedgene Technologies Ltd., Fabric Genomics Inc., FDNA Inc., Freenome Holdings Inc., GNS Healthcare, IBM Watson Health, Illumina Inc., Microsoft Corporation, Niramai Health Analytix, NVIDIA Corporation, Omron Healthcare Co. Ltd.

North America was the largest region in the cardiovascular digital solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cardiovascular digital solutions market report during the forecast period. The regions covered in the cardiovascular digital solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular digital solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cardiovascular digital solutions encompass personalized diagnostic and treatment methods employing technology such as wearables, smartphones, sensors, and AI. These tools aim to encourage adherence to lifestyle changes and empower patients in self-monitoring health interventions.

These solutions offer services such as unobtrusive testing, cardiovascular health informatics, cardiac rehabilitation programs, and more. Unobtrusive testing involves data collection without direct consent or involvement from the data creators. The components typically include devices and software, deployable either through cloud-based systems or on-premise installations. End-users of these solutions span hospitals, clinics, ambulatory care centers, and other healthcare facilities.

The cardiovascular digital solutions market research report is one of a series of new reports that provides cardiovascular digital solutions market statistics, including cardiovascular digital solutions industry global market size, regional shares, competitors with a cardiovascular digital solutions market share, detailed cardiovascular digital solutions market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular digital solutions industry. This cardiovascular digital solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular digital solutions market includes revenues earned by entities by providing services such as sensors and digital technologies, such as decision-making aids, motivating and instructive smartphone platforms, tele monitoring, and tele rehabilitation, remote patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiovascular digital solutions market also includes sale of cardiac monitoring patches, heart pumps, artificial valves, artificial implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.